Ventricular assist devices in children

Current Opinion in Cardiology

Volumn 29, Issue 1, 2014, Pages 113-121

  O'Connor, Matthew J ^a   Rossano, Joseph W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

heart failure; pediatric; ventricular assist device

Indexed keywords

ADVERSE OUTCOME; CIRCULATION; CONTINUOUS FLOW REACTOR; HEART FAILURE; HEART SINGLE VENTRICLE; HEART VENTRICLE HYPERTROPHY; HUMAN; LONG TERM CARE; PARACORPOREAL PNEUMATIC PULSATILE PUMP; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TOTAL ARTIFICIAL HEART; TREATMENT INDICATION; TREATMENT OUTCOME; VENTRICULAR ASSIST DEVICE;

CHILD; HEART FAILURE; HEART TRANSPLANTATION; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HUMANS; TREATMENT OUTCOME;

EID: 84890436591     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000030     Document Type: Review

References (42)

1. Almond CS, Singh TP, Gauvreau K, et al. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: Analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry. Circulation 2011; 123:2975-2984.
2. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 2012; 31:1052-1064. Comprehensive overview of trends in adult heart transplants and highlights the increase in VAD utilization over the past decade.
3. Almond CS, Chen EA, Berman MR, et al. High-risk medical devices, children and the FDA: Regulatory challenges facing pediatric mechanical circulatory support devices. ASAIO J 2007; 53:4-7.
4. Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: Executive summary. J Heart Lung Transplant 2013; 32:157-187. Exhaustive review and consensus document from the International Society for Heart and Lung Transplantation of the indications, complications, and outcomes of mechanical circulatory support in adults, including the use of VADs in unusual situations (e.g., CHD).
5. Miller LW, Guglin M. Patient selection for ventricular assist devices: A moving target. J Am Coll Cardiol 2013; 61:1209-1221.
6. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-2251.
7. Amodeo A, Adorisio R. Left ventricular assist device in Duchenne cardiomyopathy: Can we change the natural history of cardiac disease Int J Cardiol 2012; 161:e43.
8. Topilsky Y, Pereira NL, Shah DK, et al. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 2011; 4:266-275.
9. Gandy KL, Mitchell ME, Pelech AN, et al. Aortic exclusion: A method of handling aortic insufficiency in the pediatric population needing mechanical circulatory support. Pediatr Cardiol 2011; 32:1231-1233.
10. Rossano JW, Woods RK, Berger S, et al. Mechanical support as failure intervention in patients with cavopulmonary shunts (MFICS): Rationale and aims of a new registry of mechanical circulatory support in single ventricle patients. Congenit Heart Dis 2013; 8:182-186.
11. VanderPluym CJ, Rebeyka IM, Ross DB, Buchholz H. The use of ventricular assist devices in pediatric patients with univentricular hearts. J Thorac Cardiovasc Surg 2011; 141:588-590. Excellent description of the creative surgical approaches to successful VAD implantation often made necessary by the physiologic constraints of single ventricle anatomy.
12. Nathan M, Baird C, Fynn-Thompson F, et al. Successful implantation of a Berlin Heart biventricular assist device in a failing single ventricle. J Thorac Cardiovasc Surg 2006; 131:1407-1408.
13. Fan Y, Zhang AM, Weng YG, et al. Factors associated with the need of biventricular mechanical circulatory support in children with advanced heart failure. Eur J Cardiothorac Surg 2013; 43:1028-1035.
14. Fraser CD, Jaquiss RD, Rosenthal DN, et al. Prospective trial of a pediatric ventricular assist device. N Engl J Med 2012; 367:532-541. As mentioned in the text, this is the first randomized, controlled trial of a pediatric VAD (Berlin Heart EXCOR). Although the study has important limitations, it represents an important achievement in the care of children with end-stage heart failure.
15. Karamlou T, Gelow J, Diggs BS, et al. Mechanical circulatory support pathways that maximize postheart transplant survival. Ann Thorac Surg 2013; 95:480-485.
16. Kirklin JK, Naftel DC, Kormos RL, et al. Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 2013; 32:141-156. Although the data are exclusive to adult patients, the data contained in INTERMACS represent authoritative information on utilization and outcomes of VADs, and, in particular, highlight the improvements in outcomes with continuousflow devices compared with first-generation pulsatile devices. The development of PEDIMACS is also briefly discussed in this article.
17. Hetzer R, Alexi-Meskishvili V, Weng Y, et al. Mechanical cardiac support in the young with the Berlin Heart EXCOR pulsatile ventricular assist device: 15 years' experience. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006; 99-108.
18. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011; 57:1890-1898.
19. Fraser CD, Carberry KE, Owens WR, et al. Preliminary experience with the MicroMed DeBakey pediatric ventricular assist device. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006; 109-114.
20. Crews KA, Kaiser SL, Walczak RJ, et al. Bridge to transplant with extracorporeal membrane oxygenation followed by HeartWare ventricular assist device in a child. Ann Thorac Surg 2013; 95:1780-1782. A novel use of the centrifugal HeartWare VAD in a child, which remains rare.
21. Copeland JG, Copeland H, Gustafson M, et al. Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg 2012; 143:727-734. The TAH represents a potentially useful modality in older patients with single ventricle CHD. Although patients with CHD are not represented in these data, the results from this study provide information regarding the use, complications, and outcomes of this device.
22. Kirsch ME, Nguyen A, Mastroianni C, et al. SynCardia temporary total artificial heart as bridge to transplantation: Current results at La Pitie hospital. Ann Thorac Surg 2013; 95:1640-1646. Similar data to the previous study from a European center.
23. Ricci M, Gaughan CB, Rossi M, et al. Initial experience with the TandemHeart circulatory support system in children. ASAIO J 2008; 54: 542-545.
24. Almond CS, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 2009; 119:717-727.
25. Blume ED, Naftel DC, Bastardi HJ, et al. Outcomes of children bridged to heart transplantation with ventricular assist devices: A multiinstitutional study. Circulation 2006; 113:2313-2319.
26. Imamura M, Dossey AM, Prodhan P, et al. Bridge to cardiac transplant in children: Berlin Heart versus extracorporeal membrane oxygenation. Ann Thorac Surg 2009; 87:1894-1901.
27. Morales DL, Almond CS, Jaquiss RD, et al. Bridging children of all sizes to cardiac transplantation: The initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant 2011; 30:1-8.
28. Almond CS, Morales DL, Blackstone EH, et al. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation 2013; 127:1702-1711. This article reports outcome data on all US patients who had a Berlin Heart EXCOR VAD implanted between 2007 and 2010, and thus represents a larger cohort (207 patients) than the initial IDE trial.
29. Byrnes JW, Prodhan P, Williams BA, et al. Incremental reduction in the incidence of stroke in children supported with the Berlin EXCOR ventricular assist device. Ann Thorac Surg 2013. [Epub ahead of print]
30. Eckman PM, John R. Bleeding and thrombosis in patients with continuousflow ventricular assist devices. Circulation 2012; 125:3038-3047.
31. Meyer AL, Malehsa D, Bara C, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010; 3:675-681.
32. Bhama JK, Rayappa S, Zaldonis D, et al. Impact of abdominal complications on outcome after mechanical circulatory support. Ann Thorac Surg 2010; 89:522-529.
33. O'Connor MJ, Menteer J, Chrisant MR, et al. Ventricular assist deviceassociated antihuman leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation. J Heart Lung Transplant 2010; 29:109-116.
34. Moazami N, Itescu S, Williams MR, et al. Platelet transfusions are associated with the development of antimajor histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant 1998; 17:876-880.
35. George I, Colley P, Russo MJ, et al. Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg 2008; 135:1372-1379.
36. Rossano JW, Morales DL, Zafar F, et al. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: An analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2010; 140:694-699.
37. O'Connor MJ, Harville TO, Rhodes-Clark B, et al. Quantification, identification, and relevance of antihuman leukocyte antigen antibodies formed in association with the Berlin Heart ventricular assist device in children. Transplantation 2013; 95:1542-1547. This article reports single-center data regarding anti-HLA antibody formation in a population comprised entirely of children supported with the Berlin Heart EXCOR VAD, using current techniques of anti-HLA antibody assessment. Although the formation of anti-HLA antibodies was common, they did not appear to cause difficulty at the time of transplant with respect to HLA incompatibility (positive cross-match).
38. Kirk R, Dipchand AI, Edwards LB, et al. The registry of the International Society for Heart and Lung Transplantation: Fifteenth pediatric heart transplantation report-2012. J Heart Lung Transplant 2012; 31:1065-1072.
39. Rossano JW, Mott AR, Mohamed Z, et al. Decreasing mortality of ventricular assist devices at children's hospitals from 2000 to 2010: Improvement at a cost. Circulation 2012; 126:A11553.
40. Dardas T, Mokadam NA, Pagani F, et al. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time. J Am Coll Cardiol 2012; 60:36-43.
41. Wever-Pinzon O, Drakos SG, Kfoury AG, et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: Is reappraisal of the current United Network for Organ Sharing thoracic organ allocation policy justified Circulation 2013; 127:452-462. Intriguing data in adults suggesting that the outcomes of patients supported on VAD as part of a destination therapy strategy are superior to those listed as status 1A without VAD support.
42. Baldwin JT, Borovetz HS, Duncan BW, et al. The National Heart, Lung, and Blood Institute pediatric circulatory support program: A summary of the 5-year experience. Circulation 2011; 123:1233-1240.